QUREDOSE Trademark

Trademark Overview


On Tuesday, June 22, 2021, a trademark application was filed for QUREDOSE with the United States Patent and Trademark Office. The USPTO has given the QUREDOSE trademark a serial number of 90788287. The federal status of this trademark filing is REGISTERED as of Tuesday, August 1, 2023. This trademark is owned by uniQure IP B.V.. The QUREDOSE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the treatment of viral diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, namely, biological preparations for medical diagnostic or treatment use; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy

Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics

Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
quredose

General Information


Serial Number90788287
Word MarkQUREDOSE
Filing DateTuesday, June 22, 2021
Status700 - REGISTERED
Status DateTuesday, August 1, 2023
Registration Number7123802
Registration DateTuesday, August 1, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesViral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the treatment of viral diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, namely, biological preparations for medical diagnostic or treatment use; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
Pseudo MarkCURE DOSE
Goods and ServicesGene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Goods and ServicesResearch, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameuniQure IP B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Party NameuniQure IP B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Party NameuniQure IP B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Trademark Events


Event DateEvent Description
Tuesday, August 1, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 1, 2023REGISTERED-PRINCIPAL REGISTER
Monday, June 26, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, May 1, 2023NOTICE OF ALLOWANCE CANCELLED
Monday, June 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 1, 2023TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 23, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 20, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, January 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 14, 2022NON-FINAL ACTION E-MAILED
Monday, November 14, 2022NON-FINAL ACTION WRITTEN
Monday, October 24, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, September 6, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 28, 2022ASSIGNED TO LIE
Tuesday, July 26, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 20, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 10, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 10, 2022LETTER OF SUSPENSION E-MAILED
Thursday, February 10, 2022SUSPENSION LETTER WRITTEN
Tuesday, February 8, 2022ASSIGNED TO EXAMINER
Thursday, September 9, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, September 9, 2021ASSIGNED TO LIE
Friday, June 25, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 25, 2021NEW APPLICATION ENTERED